Why You’ll Love It
Experience the potent natural benefits of the Mediterranean with our premium Oregano Oil Capsules. Each serving provides a powerful 4,000 mg equivalent of wild-harvested Oregano Leaf, standardized to contain naturally occurring Carvacrol. Designed for those seeking a high-potency herbal supplement, these quick-release softgels are an essential addition to your daily wellness routine.
Key Features
- High Potency Formula: Delivers an equivalent of 4,000 mg of Oregano Leaf per serving for maximum efficacy.
- Standardized Carvacrol: Contains naturally occurring Carvacrol, the active compound responsible for oregano’s health-promoting properties.
- Premium Sourcing: Crafted from Mediterranean and wild-harvested oregano to ensure purity and strength.
- Clean Label: Non-GMO, Gluten-Free, Soy-Free, and Dairy-Free. Contains no artificial flavors, sweeteners, or preservatives.
- Quick Release Softgels: Designed for rapid absorption and easy swallowing.
Key Ingredients
- Oregano Oil (Origanum vulgare): Mediterranean wild-harvested extract equivalent to 4,000 mg of fresh herb.
- Carvacrol: Naturally occurring phenolic compound for antioxidant and immune support.
- Other Ingredients: Gelatin, Vegetable Glycerin (for the softgel capsule).
How to Use
For adults, take one (1) quick-release softgel daily, preferably with a meal. If you are new to oregano oil, start with one capsule to assess tolerance. Do not exceed the recommended dosage.
Frequently Asked Questions
Q: What is the benefit of Carvacrol?
A: Carvacrol is the primary active ingredient in oregano oil, known for its powerful antioxidant properties and support for the immune system.
Q: Is this product suitable for vegans?
A: This specific formulation uses a gelatin softgel; please check our alternative vegan-friendly listings if required.
Q: Where is the oregano sourced from?
A: Our oregano is wild-harvested from the Mediterranean region, ensuring the highest natural concentration of active compounds.
Dimensions & Specifications
Reviews
There are no reviews yet.